Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea- Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg)
Abstract
Authors
M Shin S Shin JY Lee J Kim J Park H Kwon